3.92
0.25 (6.81%)
| Penutupan Terdahulu | 3.67 |
| Buka | 3.67 |
| Jumlah Dagangan | 2,747,713 |
| Purata Dagangan (3B) | 2,212,336 |
| Modal Pasaran | 385,654,880 |
| Harga / Jualan (P/S) | 0.670 |
| Harga / Buku (P/B) | 0.760 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2025 |
| Margin Keuntungan | -15.96% |
| Margin Operasi (TTM) | -9.49% |
| EPS Cair (TTM) | -0.700 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 10.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2,020.06% |
| Nisbah Semasa (MRQ) | 1.79 |
| Aliran Tunai Operasi (OCF TTM) | -15.64 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 5.58 M |
| Pulangan Atas Aset (ROA TTM) | -17.66% |
| Pulangan Atas Ekuiti (ROE TTM) | -277.62% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Bercampur | Bercampur | |
| Stok | The Oncology Institute, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.50 |
|
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.22% |
| % Dimiliki oleh Institusi | 34.63% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Tiff Advisory Services, Llc | 30 Sep 2025 | 856,628 |
| Julat 52 Minggu | ||
| Median | 5.00 (27.55%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 25 Nov 2025 | 5.00 (27.55%) | Beli | 3.16 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Jan 2026 | Pengumuman | The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 Outlook |
| 09 Jan 2026 | Pengumuman | The Oncology Institute Announces Leadership Promotions |
| 05 Jan 2026 | Pengumuman | The Oncology Institute Announces Addition of Board Member Mark Stolper |
| 01 Dec 2025 | Pengumuman | The Oncology Institute Announces Resignation of Board Member Gabe Ling |
| 13 Nov 2025 | Pengumuman | The Oncology Institute Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance |
| 13 Nov 2025 | Pengumuman | Ascertain and The Oncology Institute Co-Develop ‘Touchless’ AI Automation for Oncology Administration |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |